Page 1

Table of Contents ( Mark One ) > ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K CYCLACEL PHARMACEUTICALS , INC . ( Exact name of registrant as specified in its charter ) Commission file number 00-50626 Delaware ( State or Other Jurisdiction of Incorporation or Organization ) 200 Connell Drive Suite 1500 Berkeley Heights , New Jersey ( Address of principal executive offices ) Title of each class Common Stock , par value $ 0.001 per share Preferred Stock , $ 0.001 par value 07922 ( Zip Code ) Registrant's telephone number , including area code : ( 908 ) 517-7330 Securities registered pursuant to section 12 ( b ) of the Act : None 91-1707622 ( I.R.S. Employer Identification No. ) Trading Symbol ( s ) CYCC CYCCP Securities registered pursuant to section 12 ( g ) of the Act : None . Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes No Indicate by check mark whether the registrant : ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No Large accelerated filer Non - accelerated filer Emerging growth company Indicate by check mark whether the registrant has submitted electronically , every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes > No ■ Name of each exchange on which registered The Nasdaq Stock Market LLC The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , or a smaller reporting company . See the definitions of “ large accelerated filer , ” “ accelerated filer ” and “ smaller reporting company ” in Rule 12b - 2 of the Exchange Act : Accelerated filer Smaller reporting company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . The aggregate market value of the registrant's voting and non - voting common stock held by non - affiliates of the registrant ( without admitting that any person whose shares are not included in such calculation is an affiliate ) , as of June 30 , 2020 ( based upon the closing sale price of $ 4.65 of such shares on The NASDAQ Capital Market on June 30 , 2020 ) , the last business day of the registrant's most recently completed second fiscal quarter , was $ 22,609,904 . As of February 24 , 2021 , there were 7,103,650 shares of the registrant's common stock outstanding . DOCUMENTS INCORPORATED BY REFERENCE